Integrated bioinformatics analysis reveals that CCBP2 and GPR87 are new GPCR-associated biomarkers for preeclampsia Authors: Jie Li, Meng-Meng Chen, Bingqiang Zhang, Yi Zhao Published: 2024 ABSTRACT AbstractBackgroundPreeclampsia (PE) is a multifaceted pregnancy syndrome marked by multiple system involvement and a significant contributor to maternal mortality. This condition is characterized by a critical lack of early diagnostic measures and viable therapeutic options, underscoring an urgent need for the identification of reliable markers with both diagnostic and therapeutic potential.MethodsThis study utilized Weighted Gene Co-expression Network Analysis (WGCNA) to explore the role of G protein-coupled receptors (GPCRs) in the pathogenesis of PE.ResultsOur analysis pinpointed CCBP2 (ACKR2) and GPR87 as central PE-associated GPCRs. Experimental validation of these findings revealed that both CCBP2 and GPR87 significantly inhibit the proliferation, migration, and invasion of trophoblast cells—core phenomena underlying the pathology of PE.ConclusionThus, our findings add valuable candidates to the growing list of biomarkers for preeclampsia and offer promising targets for future therapeutic development.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12958-024-01324-5.Keywords: Preeclampsia (PE), Weighted Gene Co-expression Network Analysis (WGCNA), G protein-coupled receptors (GPCRs), Biomarkers Background Preeclampsia (PE), also referred to as antepartum eclampsia, is a common and severe pregnancy complication, characterized primarily by hypertension and proteinuria [1, 2]. There is currently a lack of measures to diagnose the early onset of PE despite continuous advancements in modern medicine, and treatment options remain limited. PE is one of the primary causes of maternal and neonatal mortality globally [3]. Therefore, the discovery of reliable biomarkers with diagnostic and therapeutic value holds significant importance in enhancing the comprehensive management of pregnant women affected by PE. PE is a complex disorder involving a multitude of physiological and pathological factors [4]. Its occurrence may be associated with endothelial cell dysfunction, immune system dysregulation, and genetic factors [1, 5, 6]. Poor infiltration of decidual trophoblasts is also one of the major causes of PE development [7]. Additionally, paternal factors such as age, genetic predisposition, and lifestyle are potential risk factors. Maternal factors, including age, multiple gestation, obesity, and diabetes, also contribute to the development of eclampsia [1, 5, 8, 9]. Currently, the exact etiology and pathogenic mechanisms regulating PE are not fully understood. Research suggests that abnormalities in intracellular signal transduction may contribute to the development of PE [10, 11]. G protein-coupled receptors (GPCRs) are a class of large transmembrane proteins located on the cell membrane. They serve as crucial molecules in signal transduction, acting as bridges between extracellular signals (including hormones, neurotransmitters, and chemokines) and intracellular responses. Binding of external signal molecules to GPCRs activates intracellular G proteins, triggering a cascade of signaling events that affect cellular physiological functions [12]. Research has recently suggested a potentially pivotal role of GPCRs in PE [11]. Moreover, as a hot target in the field of drug development, GPCR-related targets such as the calcitonin receptor-like receptor (CRLR) affecting vascular dilation and angiotensin II have significant potential in improving PE symptoms and extending safe pregnancies [13]. Hence, the identification of GPCR-related biomarkers also provides potential targets for the development of new drugs. Some studies have attempted to identify susceptible genes associated with PE to use as diagnostic and therapeutic targets [14–17]. Analyses focusing specifically on core GPCRs related to PE are scarce. Moreover, most studies have focused on identifying PE-related biomarkers through differential analysis, often overlooking gene interactions and co-regulatory relationships. Weighted Gene Co-Expression Network Analysis (WGCNA) is a system biology approach used for mining gene co-expression patterns, enabling the identification of modular gene networks while preserving the relationships among genes [18]. To our knowledge, only one study has used WGCNA to identify PE-associated GPCRs [19]. Nonetheless, this study only focused on a single dataset, failing to pinpoint the core PE-related GPCRs. Therefore, this study used WGCNA to screen and identify GPCRs associated with PE that hold diagnostic and therapeutic value. The goal was to provide a theoretical basis for unraveling the molecular mechanisms underlying PE development and developing innovative therapeutic strategies for targeting PE. Materials and methods Dataset collection and preprocessing Datasets GSE75010 and GSE73374 were selected and downloaded from the GEO database. Both consist of human placental transcriptome data. GSE75010 (GPL6244), extracted solely from BioBank, includes 77 control samples and 80 PE samples [20, 21]. GSE73374 (GPL16686) included 17 control samples and 19 PE samples [22] (Supplementary Table 1). Probe annotation information for the respective GPL platform was used to annotate probes into the corresponding gene symbols, and unannotated probes were removed. Additionally, a list of 326 GPCRs was extracted from a previous article [23]. Analysis of weighted gene co-expression network The gene expression matrix, annotated and normalized, was subjected to outlier removal and Pearson correlation analysis to compute the inter-gene relationships, leading to the construction of a correlation matrix. An appropriate soft threshold was calculated based on this matrix to define network connection weights, transforming the correlation matrix into a Topological Overlap Matrix (TOM). Gene connectivity in the network was assessed using the TOM, and hierarchical clustering was used to establish gene modules, each representing a set of genes with similar expression patterns. Subsequently, the average expression profile of genes in each module was correlated with the external phenotype to identify modules most closely associated with PE. All analyses were performed using the R package “WGCNA”. Hub PE-related GPCRs screening The PE-related gene interaction was obtained from WGCNA analysis. Cytoscape was used for visualizing the interaction network. The top 20 key genes were extracted using Cytohubba with the following four algorithms: maximum neighborhood component (MNC), maximal clique centrality (MCC), Degree (degree of a node in the network) of Network-based Method with Clustering Analysis (DNMC), and Degree. LASSO regression with 7-fold cross-validation was used for the selection of the PE-related feature, performed using the “glmnet” R package. The genes obtained from both methods were intersected to identify hub genes. Hub PE-related GPCRs validation The R packages “ggplot2,” “stats,” and “car” were used for validating the differential expression of hub GPCRs. The “ggplot2” package was used for graphical representation, while the “stats” package facilitated statistical analyses. Additionally, the “car” package was used to enhance the robustness of statistical testing. ROC curves were generated using the “pROC” package to assess the diagnostic performance of hub GPCRs. Cell culture and transfection Immortalized human trophoblast cell line HTR-8/SVneo was obtained from Saibainuo Limited Company Biotechnology Corporation (Shanghai). Cells were cultured in 1640 medium (Meilunbio, Dalian, China) containing 1% penicillin-streptomycin (Meilunbio, Dalian, China) and 10% fetal bovine serum (Meilunbio, Dalian, China) at 37 °C with 5% CO2. CCBP2 siRNA and GPR87 siRNA (Tsingke, Wuhan, China) were separately transfected into HTR8/SVneo cells using Lipo8000TM (Beyotime). Each siRNA was diluted and transfected according to the recommended dilution ratios provided in the product instructions. Cells were collected 48 h after transfection for subsequent experiments. Western blot analysis Cell total proteins were extracted using RIPA lysis buffer (Solarbio) containing PMSF (Solarbio, Beijing, China) and a proteinase inhibitor (Meilunbio). The extracted proteins (20 µg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a PVDF membrane (Millipore). The membrane was treated with the primary antibodies CCBP2 (1:1000, A05491-2, Boster, Wuhan, China) GPR87 (1:1000, DF4798, Affinity, Jiangsu, China), and β-actin(1:5000, BM0627, Boster), the latter used as the loading control and incubated overnight at 4 °C. Next, the membrane was treated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000, BA1050/1054, Boster) and incubated at room temperature for 1 h. ImageJ software was used for the quantitative analysis based on grayscale values. Cell proliferation assay Cells transfected with siCCBP2, siGPR87, and their corresponding negative controls were seeded in a 96-well plate (1 × 10^3 cells/well). Cell Counting Kit-8 (CCK8) solution (10 µl, Meilunbio) was added at 24, 48, 72, and 96 h post-culture and incubated for 2 h at 37 °C under 5% CO2. Cell proliferation was assessed by measuring the absorbance at 450 nm. Wound healing assay Transfected cells were seeded in a 6-well plate and incubated for at least 24 h until reaching the confluence. A sterile yellow micropipette tip (200 µl) was used to create a wound in the monolayer of cells. Detached cell fragments were removed by washing with PBS and the cells were further incubated in culture medium without FBS. Cell images were captured at 0 h and 24 h post-wounding. ImageJ software was used to process the images and calculate the wound closure rate. Migration and invasion assays Transwell chambers (8.0 μm, CORNING, Shanghai, China) were placed into the lower part of a 12-well plate. The transfected cells were resuspended in serum-free RPMI 1640 medium, and 200 µL cell suspension (1 × 10^5 cells/mL) was added to the upper chamber, which was either coated with Matrigel (1 mg/ml, BD Biosciences) (for invasion assays) or left uncoated (for migration assays). Then, 500 µL RPMI 1640 medium containing 10% FBS was added to the lower chamber. After 24 h of incubation, the upper chambers were removed, and the non-migrated/invaded cells were gently wiped off. The cells that had migrated or invaded to the lower surface of the membrane were fixed with 4% paraformaldehyde (Solarbio Science) for 15 min, followed by staining with 0.1% crystal violet. Images were captured under a microscope, and the number of invasive cells was quantified using ImageJ software. Statistical analysis Statistical analysis was performed using R (version 4.1.2) and GraphPad Prism (version 9.4.1). Student t-test was used for the comparison of two groups. Results are expressed as mean ± SD/SEM. A value of p < 0.05 was considered statistically significant. Results Construction of the co-expression network A total of 157 samples (Control: 77, PE: 80), were obtained from the GSE75010 dataset. Gene expression in the samples was normalized, and a clustering analysis was performed with a height threshold set at 90 to remove outliers (Fig. 1A). Consequently, 155 samples (Control: 76, PE: 79) were included in the subsequent WGCNA analysis. Gene connection weights were established using Pearson correlation coefficients, and a soft power of 5 (R2 = 0.9) was selected for further analysis (Fig. 1B). Highly correlated genes were assembled into modules using hierarchical clustering analysis, resulting in the identification of 23 distinct modules (Fig. 1C). A heatmap showing the correlation between modules and traits revealed a strong association between the blue module and PE (r = 0.64, p < 0.001; Fig. 1D). The distribution of genes in the blue module is shown in the scatter plot (Fig. 1E). The blue module was subsequently chosen for further analysis (Supplementary Table 2). Construction of the WGCNA co-expression network for the GSE75010 dataset. (A) Sample clustering and removal of outliers. (B) Scale-free index under different soft-thresholding powers. (C) Hierarchical clustering analysis identifying gene co-expression modules with different color assignments, recognizing a total of 23 gene modules. (D) Heatmap depicting the correlation between gene modules and preeclampsia (PE), where the red indicates a positive correlation, and the green indicates a negative correlation. Each cell is annotated with the correlation coefficient and p value. (E) Scatter plot illustrating the gene significance (GS) within the blue module correlated with module membership (MM). The x-axis represents the correlation between genes and the module, while the y-axis represents the correlation between genes and PE traits A parallel analysis using two datasets was performed to enhance the stability and reliability. A total of 36 samples (Control: 17, PE: 19) were obtained from the GSE73374 dataset, and data preprocessing procedures were consistent with the previous dataset analysis, with no observed outliers (Fig. 2A). Therefore, all samples were used for subsequent analysis. A total of 16 modules were identified after applying a soft threshold of 8 (R2 = 0.9) (Fig. 2B-C). The correlation heatmap revealed that the magenta module exhibited the strongest correlation with PE (r = 0.39, p = 0.02; Fig. 2D). This observation was further supported by the scatter plot visualizing the gene distribution within the magenta module (Fig. 2E). Therefore, the magenta module was selected for subsequent analysis (Supplementary Table 2). Construction of the WGCNA co-expression network for the GSE73374 dataset. (A) Sample clustering without observed outliers. (B) Scale-free index under different soft-thresholding powers. (C) Hierarchical clustering analysis identifying gene co-expression modules with different color assignments, recognizing a total of 16 gene modules. (D) Heatmap depicting the correlation between gene modules and PE, where the red indicates a positive correlation, and the green indicates a negative correlation. Each cell is annotated with the correlation coefficient and p value. (E) Scatter plot illustrating the GS within the magenta module correlated with MM. The x-axis represents the correlation between genes and the module, while the y-axis represents the correlation between genes and PE traits Selection of hub PE-related GPCRs The module gene interaction weight (Supplementary Table 3) based on the blue module for the GSE75010 dataset was loaded into Cytoscape, generating a visual network with 1071 nodes and 199,837 edges (Fig. 3A). The top 20 hub genes in the network were identified by the first four algorithms MNC (Fig. 3B), MCC (Fig. 3C), Degree (Fig. 3D), and DMNC (Fig. 3E) of cytoHubba plugin, which were intersected with 326 GPCRs extracted from previous literature (Supplementary Table 4), and CCBP2 (ACKR2) was obtained as the hub PE-related GPCRs. Selection of hub PE-related GPCRs in the GSE75010 dataset. (A) Network plot of gene co-expression weights in the blue module. Top 20 hub genes in the interaction network identified by CytoHubba using MNC (B), MCC (C), Degree (D), and DMNC (E) algorithms. (F) Profile plot of coefficient values in the LASSO regression for independent variables. (G) Partial likelihood deviance plot for LASSO regression Additionally, the genes in the blue module were intersected with the GPCRs list to provide more reliable and comprehensive results, yielding 12 PE-related GPCRs (CELSR1, GPR111, ADORA2A, EDNRB, TACR3, OPRK1, GPR3, CCR7, CCBP2, GPR17, HRH1, and P2RY2). Ten GPCRs (CELSR1, GPR111, ADORA2A, EDNRB, TACR3, OPRK1, GPR3, CCBP2, GPR17, and HRH1) with non-zero coefficients were further extracted as hub PE- related GPCRs (Fig. 3F-G) using the LASSO regression algorithm. In conclusion, both methods jointly identified CCBP2 (ACKR2) as a hub PE-related GPCR in the GSE75010 dataset. The module gene interaction weight (Supplementary Table 5) based on the magenta module for the GSE73374 dataset was loaded into Cytoscape to generate a visualization network containing 298 nodes and 17,105 edges (Fig. 4A). The first 4 algorithms of MNC (Fig. 4B), MCC (Fig. 4C), Degree (Fig. 4D), and DMNC (Fig. 4E) of cytoHubba plugin mentioned above identified the top 20 hub genes in the network, respectively, which were intersected with the above list of GPCRs, and screened to obtain CCR1 and GPR87 as hub PE-associated GPCRs. Similarly, directly intersecting the genes in the magenta module with the GPCR list identified six PE-related GPCRs (CCR1, CXCR6, GALR2, GNRHR, GPR87, and SSTR2). GPR87 was further screened as a hub PE-related GPCR by the LASSO algorithm (Fig. 4F-G). Both methods jointly identified GPR87 as a hub PE-related GPCR in the GSE73374 dataset. Ultimately, a total of two hub PE-related GPCRs (CCBP2 (ACKR2) and GPR87) were found in the two datasets. Selection of hub PE-related GPCRs in the GSE73374 dataset. (A) Network plot of gene co-expression weights in the magenta module. Top 20 hub genes in the interaction network identified by CytoHubba using MNC (B), MCC (C), Degree (D), and DMNC (E) algorithms. (F) Profile plot of coefficient values in the LASSO regression for independent variables. (G) Partial likelihood deviance plot for LASSO regression Verification of hub PE-related GPCRs The expression of hub PE-related GPCRs was confirmed using publicly available datasets. Both CCBP2 (ACKR2) and GPR87 were upregulated in the PE placental expression profiles compared to normal placenta controls (p < 0.05; Fig. 5A-C), while GPR87 did not reach statistical significance in one dataset, although an observable upregulation in PE was noted (p = 0.06; Fig. 5D). Verification of hub PE-related GPCRs. Expression profiles of CCBP2 (A) and GPR87 (B) genes in the GSE75010 dataset. Expression profiles of CCBP2 (C) and GPR87 (D) genes in the GSE75010 dataset. ROC diagnostic curves for CCBP2 (E) and GPR87 (F) genes in the GSE75010 dataset. ROC diagnostic curves for CCBP2 (G) and GPR87 (H) genes in the GSE73374 dataset. *p < 0.05; ** p < 0.01; *** p < 0.001 The diagnostic efficacy of the two hub PE-related GPCRs was assessed using ROC curve analysis. CCBP2 (ACKR2) showed excellent diagnostic performance in both datasets (AUC: 0.806, AUC: 0.706; Fig. 5E-G). Unfortunately, the diagnostic performance of GPR87 was moderate and lower to CCBP2 (ACKR2) (AUC: 0.642, AUC: 0.684; Fig. 5F and H). CCBP2 and GPR87 inhibit HTR8/SVneo cell proliferation, migration, and invasion To further investigate the biological functions of CCBP2 and GPR87 in PE development, we individually transfected siRNAs to downregulate CCBP2 or GPR87 protein expression in HTR8/SVneo cells (Fig. 6A). CCK8 assays demonstrated that downregulation of either CCBP2 or GPR87 significantly promoted HTR8/SVneo cell proliferation (Fig. 6B). Downregulation of CCBP2 or GPR87 expression led to increased healing area in wound healing assays (Fig. 6C), and an increase in the number of invading and migrating HTR8/SVneo cells in Transwell assays (Fig. 6D). These results suggest that individual knockdown of CCBP2 or GPR87 promotes the proliferation, migration, and invasion of HTR8/SVneo cells in vitro. CCBP2 and GPR87 inhibit HTR8/SVneo cell proliferation, migration, and invasion. Efficiency of CCBP2 (A) and GPR87 (B) knockdown in HTR8/SVneo cells detected by western blot. Proliferation curves of siCCBP2 (C) and siGPR87 (D) compared with the blank control in HTR8/SVneo cells as determined by CCK8 assay. Representative images and quantitative analysis of wound healing assay for siCCBP2 (E) and siGPR87 (F) compared with the blank control in HTR8/SVneo cells. Scale bar, 100 μm. Representative images and quantitative analysis of Transwell assays for siCCBP2 (G) and siGPR87 (H) compared with the blank control in HTR8/SVneo cells depicting cell migration and invasion. Scale bar, 300 μm. The above experiments were repeated three times Discussion PE is a serious disease that significantly threatens maternal and fetal health. Despite extensive research into its pathogenesis, the mechanisms underlying PE remain incompletely understood [24]. GPCRs are a class of membrane proteins that participate in various physiological processes by responding to extracellular signals. Although GPCRs currently account for approximately 30% of drug development targeting them, most family members remain unexplored in therapeutic or clinical trials [25]. Two datasets were used in this study, and WGCNA was applied to identify hub PE-related GPCRs, leading to the identification of two critical modules. Combining CytoHubba topological analysis with the LASSO regression algorithm led to the identification of CCBP2 (ACKR2) and GPR87 as hub PE-related GPCRs. A study indicates that dysregulated chemokines participate in the pathogenesis of PE by modulating trophoblast cell biological behavior [26]. CCBP2 belongs to the atypical chemokine receptor family and is expressed in non-hematopoietic cells and lymphatic endothelial cells in the skin, intestine, and lungs [27]. Additionally, CCBP2 is expressed in human placental tissues, especially in placental trophoblast cells [28]. Based on current research, CCBP2 plays a crucial role in maintaining the inflammatory balance at the maternal-fetal interface by clearing chemokines, thereby mitigating immune overactivation and suppressing inflammation at the maternal-fetal interface [29]. These studies collectively highlight the potential role of CCBP2 in suppressing the inflammatory response. The current focal point in PE research is based on the hypothesis of excessive activation of the inflammatory immune response. Various inflammatory factors released by the placenta enter the bloodstream through the maternal-fetal interface barrier, leading to the overactivation of the body’s immune inflammatory response [27]. However, our study observed elevated expression of CCBP2 in PE, which we hypothesize may reflect a feedback mechanism of the maternal-fetal interface in response to excessive inflammatory activation, aiming to mitigate inflammation through enhanced chemokine clearance. Therefore, the increased expression of CCBP2 is more likely a consequence of PE rather than a direct causative factor. Further research is required to elucidate the specific regulatory mechanisms of CCBP2 under pathological conditions such as placental hypoxia and oxidative stress. Lysophosphatidic acid (LPA) is a widely distributed phospholipid in the human body that functions as an extracellular signaling molecule involved in various pathological processes, including cell proliferation and migration [30]. It is a ligand for GPCRs, also known as LPA receptors, and exerts its biological functions through these receptors. Among these, GPR87 has been identified as a novel LPA receptor [31], and is involved in the occurrence and development of various cancers, including pancreatic, bladder, and lung cancer [32–34]. Therefore, GPR87 became a promising cancer treatment target, but its role in the occurrence of PE has not been reported to date. Recent studies focusing on the pathogenesis of PE are increasing their attention on lipid signaling. Research suggests that the molecular signal transduction of lipid mediators is involved in various reproductive processes, including placental implantation and the maintenance of pregnancy [35]. Given the role of GPR87 in lipid signaling, our hypothesis was that GPR87 might be a promising therapeutic target for PE. Extravillous trophoblasts (EVT) are responsible for the invasion and implantation of the endometrium [36]. The growth of EVT in the early pregnancy resembles that of malignant tumor cells, since they directly invade the decidua and parts of the uterine muscle layer, leading to poor spiral artery dilation and inadequate placental perfusion [37]. Defects in EVT migration and invasion result in improper remodeling of uterine spiral arteries; thus, the failure of EVT migration and invasion is associated with the pathogenesis of PE [37]. HTR8/SVneo trophoblast cells are derived from the nutritive layer cells of a normal early pregnancy placenta and represent non-tumor cells closely resembling human placental trophoblast cells [38]. During placental development, HTR8/SVneo cells mimic the invasion of extravillous trophoblasts into the decidua, replace endothelial cells, and reshape uterine spiral arteries [39]. Therefore, HTR8/SVneo cells are commonly used in vitro experiments to study proliferation, invasion, migration, and vascular formation of extravillous trophoblasts. Considering the trend of high expression of CCBP2 and GPR87 in PE, we constructed CCBP2 knockdown and GPR87 knockdown HTR8/SVneo cell lines using siRNA interference. CCK8 proliferation assays showed that inhibition of either CCBP2 or GPR87 expression led to a decrease in HTR8/SVneo cell proliferation. Scratch wound healing and Transwell assays indicated that suppression of CCBP2 or GPR87 expression enhanced the migration and invasion of HTR8/SVneo cells. These results are consistent with the typical pathological changes observed in PE, where migration and invasion are impaired; however, the specific mechanisms require further investigation. Currently used clinical biomarkers for PE, such as the sFlt-1/PlGF ratio, cfRNA, and placenta-specific angiogenic microRNAs, have shown effectiveness in early diagnosis and disease monitoring [40–42]. However, the performance and accuracy of these biomarkers vary across different PE subtypes. CCBP2 and GPR87, as newly identified potential biomarkers related to PE in this study, may provide new insights into the diagnosis and pathological research of PE. CCBP2 reflects the inflammatory state of the placenta, while GPR87 may be associated with placental proliferation and lipid signaling abnormalities. Both CCBP2 and GPR87 could complement the current biomarker panels, and combined with the detection of sFlt-1, PlGF, and other markers, may improve diagnostic specificity and sensitivity. For example, CCBP2 can provide further information on the inflammatory state in PE patients, and when used alongside the sFlt-1/PlGF ratio, may help differentiate inflammation-driven PE types. GPR87 can enhance the monitoring of lipid-mediated signaling imbalances, providing distinct pathological information and making multi-biomarker-based diagnostic methods more comprehensive and accurate. Future experiments, including large-scale clinical validation, functional assays, and multi-biomarker analysis, will help assess the applicability of these markers in PE diagnosis and promote early detection and personalized treatment of PE. Conclusions This study identified CCBP2 and GPR87 as potential diagnostic and therapeutic biomarkers for PE. Our research findings indicated an upregulation of CCBP2 and GPR87 expression in PE, demonstrating their inhibitory effects on the proliferation, migration, and invasion of trophoblast cells. Further investigations are required to clarify the precise regulatory mechanisms used by CCBP2 and GPR87 to modulate the function of trophoblast cells. In conclusion, our study provides new candidate biomarkers for the diagnosis and treatment of PE. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Acknowledgements We are grateful to the developers of the online databases used in this manuscript. Author contributions J. L.: Data curation, Writing-Original draft preparation. M.M.C.: Methodology, Software. B. Q. Z.: Visualization, Writing-Reviewing. Y. Z.: Supervision; Conceptualization, Methodology, Software; Writing-Reviewing and Editing designed; Funding acquisition. All authors approved the manuscript. Funding This work was supported by the Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China Opening Fund (2023004); the National Natural Science Foundation of China (82202926); China Postdoctoral Science Foundation Special Funding (2023T160346); The Excellent Youth Science Fund Project (Overseas) of Shandong China (2024HWYQ-070); Qingdao Postdoctoral Applied Research Project (QDBSH20230101025). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate This article does not contain any study with human subjects or experimental animals. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Data Availability Statement No datasets were generated or analysed during the current study.